Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02006420 · ClinicalTrials.gov registry record

Scleroderma ARFI Imaging of the Skin

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
45
Enrollment target

NCT02006420: Completed study, sponsored by University of Michigan.

NCT02006420 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02006420 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

Scleroderma and other rheumatologic conditions can affect the skin. Scleroderma in particular involves skin thickening and hardening. Currently, looking at the degree that the skin is affected by scleroderma is measured based on a combination of a physical exam and a skin biopsy. The researchers propose to measure skin hardness using ultrasound imaging of elasticity. They will use a technique using acoustic radiation force impulse/shear wave velocity imaging , known as ARFI/SVI). The investigators hypothesize that ARFI/SVI may be able to distinguish between normal skin and skin affected by scleroderma.. This tool may also help to quantify the amount of fibrosis in the skin. This type of radiologic biomarker could be used to help confirm the diagnosis of scleroderma.

Primary Outcome

Skin stiffness was measured from the forearm and thigh of patients with scleroderma using ultrasound shear wave velocity imaging. Shear wave velocity is measured in meters per second (m/s).

Interventions

  • DEVICE ARFI-SVI Ultrasound

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2013-12
Est. Completion 2015-12
University of Michigan

1,327 total trials

What the finished NCT02006420 record still lists

NCT02006420 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which ARFI-SVI Ultrasound is the first listed.

NCT02006420 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02006420 about?

NCT02006420 is a clinical study titled "Scleroderma ARFI Imaging of the Skin". Scleroderma and other rheumatologic conditions can affect the skin. Scleroderma in particular involves skin thickening and hardening. Currently, looking at the degree that the skin is affected by scleroderma is measured based on a combination of a physical exam and a skin biopsy. The researchers p...

What is the current status of trial NCT02006420?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2013-12. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02006420?

The interventions under investigation include: ARFI-SVI Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT02006420?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02006420, the US trial registry maintained by the National Library of Medicine. NCT02006420 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.